TY - JOUR
T1 - Fatty acid-binding protein 3 is critical for α-synuclein uptake and mpp+-induced mitochondrial dysfunction in cultured dopaminergic neurons
AU - Kawahata, Ichiro
AU - Bousset, Luc
AU - Melki, Ronald
AU - Fukunaga, Kohji
N1 - Funding Information:
Funding: This research was funded by the Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development, AMED (JP18dm0107071 and JP19dm0107071) to K.F., Japan Society for the
Funding Information:
This research was funded by the Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development, AMED (JP18dm0107071 and JP19dm0107071) to K.F., Japan Society for the Promotion of Science, KAKENHI (19K07097), Kobayashi Foundation, Intelligent Cosmos Academic Foundation to I.K. and the Centre National de la Recherche Scientifique, the Fondation Simone et Cino Del Duca of the Institut de France, the Fondation Bettencourt-Schueller, the Fondation Recherche M?dicale (Contract DEQ 20160334896), and the EC Joint Programme on Neurodegenerative Diseases TransPathND, ANR-17-JPCD-0002-02 to R.M.
Funding Information:
Promotion of Science, KAKENHI (19K07097), Kobayashi Foundation, Intelligent Cosmos Academic Foundation to I.K. and the Centre National de la Recherche Scientifique, the Fondation Simone et Cino Del Duca of the Institut de France, the Fondation Bettencourt-Schueller, the Fondation Recherche Médicale (Contract DEQ 20160334896), and the EC Joint Programme on Neurodegenerative Diseases TransPathND, ANR-17-JPCD-0002-02 to R.M.
Publisher Copyright:
© 2019 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2019/11/1
Y1 - 2019/11/1
N2 - α-Synuclein is an abundant neuronal protein that accumulates in insoluble inclusions in Parkinson′s disease and other synucleinopathies. Fatty acids partially regulate α-Synuclein accumulation, and mesencephalic dopaminergic neurons highly express fatty acid-binding protein 3 (FABP3). We previously demonstrated that FABP3 knockout mice show decreased α-Synuclein oligomerization and neuronal degeneration of tyrosine hydroxylase (TH)-positive neurons in vivo. In this study, we newly investigated the importance of FABP3 in α-Synuclein uptake, 1-methyl-4-phenylpyridinium (MPP+)-induced axodendritic retraction, and mitochondrial dysfunction. To disclose the issues, we employed cultured mesencephalic neurons derived from wild type or FABP3−/− C57BL6 mice and performed immunocytochemical analysis. We demonstrated that TH+ neurons from FABP3+/+ mice take up α-Synuclein monomers while FABP3−/− TH+ neurons do not. The formation of filamentous α-Synuclein inclusions following treatment with MPP+ was observed only in FABP3+/+, and not in FABP3−/− neurons. Notably, detailed morphological analysis revealed that FABP−/− neurons did not exhibit MPP+-induced axodendritic retraction. Moreover, FABP3 was also critical for MPP+-induced reduction of mitochondrial activity and the production of reactive oxygen species. These data indicate that FABP3 is critical for α-Synuclein uptake in dopaminergic neurons, thereby preventing synucleinopathies, including Parkinson′s disease.
AB - α-Synuclein is an abundant neuronal protein that accumulates in insoluble inclusions in Parkinson′s disease and other synucleinopathies. Fatty acids partially regulate α-Synuclein accumulation, and mesencephalic dopaminergic neurons highly express fatty acid-binding protein 3 (FABP3). We previously demonstrated that FABP3 knockout mice show decreased α-Synuclein oligomerization and neuronal degeneration of tyrosine hydroxylase (TH)-positive neurons in vivo. In this study, we newly investigated the importance of FABP3 in α-Synuclein uptake, 1-methyl-4-phenylpyridinium (MPP+)-induced axodendritic retraction, and mitochondrial dysfunction. To disclose the issues, we employed cultured mesencephalic neurons derived from wild type or FABP3−/− C57BL6 mice and performed immunocytochemical analysis. We demonstrated that TH+ neurons from FABP3+/+ mice take up α-Synuclein monomers while FABP3−/− TH+ neurons do not. The formation of filamentous α-Synuclein inclusions following treatment with MPP+ was observed only in FABP3+/+, and not in FABP3−/− neurons. Notably, detailed morphological analysis revealed that FABP−/− neurons did not exhibit MPP+-induced axodendritic retraction. Moreover, FABP3 was also critical for MPP+-induced reduction of mitochondrial activity and the production of reactive oxygen species. These data indicate that FABP3 is critical for α-Synuclein uptake in dopaminergic neurons, thereby preventing synucleinopathies, including Parkinson′s disease.
KW - 1-methyl-4-phenylpyridinium (MPP)
KW - Fatty acid-binding protein 3
KW - Mitochondria
KW - Parkinson’s disease
KW - Synucleinopathy
KW - α-Synuclein
UR - http://www.scopus.com/inward/record.url?scp=85074268620&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074268620&partnerID=8YFLogxK
U2 - 10.3390/ijms20215358
DO - 10.3390/ijms20215358
M3 - Article
C2 - 31661838
AN - SCOPUS:85074268620
SN - 1422-0067
VL - 20
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
IS - 21
M1 - 5358
ER -